Zantac / Ranitidine (NDMA Cancer) Lawsuit in Delaware

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Written By
People's Justice Legal Research Team

Statute of Limitations

Delaware imposes a 2-year statute of limitations for personal injury claims (10 Del. C. § 8119). The discovery rule applies. Delaware applies the Daubert standard under D.R.E. 702, but Judge Medinilla in the Delaware Superior Court Zantac coordination has allowed plaintiffs' causation experts to proceed, distinguishing Delaware from the federal MDL's Daubert exclusion. Delaware is the primary active national venue for Zantac litigation as of 2025-2026.

2 years from date of cancer diagnosis discovery (Delaware Superior Court — most favorable active venue)

Delaware Data

Exposure in Delaware

Source: Delaware Superior Court dockets 2025

Source: Delaware Superior Court case management orders

Medical Resources

Clinics & Specialists in Delaware

Helen F. Graham Cancer Center & Research Institute (ChristianaCare)

Tunnel Cancer Center (Beebe Healthcare)

Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview